Detalles de la búsqueda
1.
Modeling Severe Fever with Thrombocytopenia Syndrome Virus Infection in Golden Syrian Hamsters: Importance of STAT2 in Preventing Disease and Effective Treatment with Favipiravir.
J Virol
; 91(3)2017 Feb 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-27881648
2.
Nab-paclitaxel versus solvent-based paclitaxel in neoadjuvant chemotherapy for early breast cancer (GeparSepto-GBG 69): a randomised, phase 3 trial.
Lancet Oncol
; 17(3): 345-356, 2016 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-26869049
3.
A randomized phase 2 study comparing EC or CMF versus nab-paclitaxel plus capecitabine as adjuvant chemotherapy for nonfrail elderly patients with moderate to high-risk early breast cancer (ICE II-GBG 52).
Cancer
; 121(20): 3639-48, 2015 Oct 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-26111104
4.
Comparison of pegfilgrastim on day 2 vs. day 4 as primary prophylaxis of intense dose-dense chemotherapy in patients with node-positive primary breast cancer within the prospective, multi-center GAIN study: (GBG 33).
Support Care Cancer
; 19(11): 1789-95, 2011 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-20953803
5.
Pathogenesis of Rift Valley Fever Virus Aerosol Infection in STAT2 Knockout Hamsters.
Viruses
; 10(11)2018 11 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-30463176
6.
A randomised trial of goserelin versus control after adjuvant, risk-adapted chemotherapy in premenopausal patients with primary breast cancer - GABG-IV B-93.
Eur J Cancer
; 43(16): 2351-8, 2007 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-17897821
7.
Heartland virus infection in hamsters deficient in type I interferon signaling: Protracted disease course ameliorated by favipiravir.
Virology
; 511: 175-183, 2017 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-28865344
8.
Tamoxifen versus control after adjuvant, risk-adapted chemotherapy in postmenopausal, receptor-negative patients with breast cancer: a randomized trial (GABG-IV D-93)--the German Adjuvant Breast Cancer Group.
J Clin Oncol
; 23(31): 7842-8, 2005 Nov 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-16258087
9.
CMF versus goserelin as adjuvant therapy for node-negative, hormone-receptor-positive breast cancer in premenopausal patients: a randomised trial (GABG trial IV-A-93).
Eur J Cancer
; 42(12): 1780-8, 2006 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-16765589
10.
Sorafenib in the Treatment of Early Breast Cancer: Results of the Neoadjuvant Phase II Study - SOFIA.
Breast Care (Basel)
; 9(3): 169-74, 2014 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-25177258
11.
German adjuvant intergroup node-positive study: a phase III trial to compare oral ibandronate versus observation in patients with high-risk early breast cancer.
J Clin Oncol
; 31(28): 3531-9, 2013 Oct 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-23980081
12.
Serum osmolality and effects of water deprivation in captive Asian elephants (Elephas maximus).
J Vet Diagn Invest
; 24(4): 688-95, 2012 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-22643341
13.
Effect of luteinizing hormone-releasing hormone agonist on ovarian function after modern adjuvant breast cancer chemotherapy: the GBG 37 ZORO study.
J Clin Oncol
; 29(17): 2334-41, 2011 Jun 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-21537042
14.
Dose-intensified epirubicin versus standard-dose epirubicin/cyclophosphamide followed by CMF in breast cancer patients with 10 or more positive lymph nodes: results of a randomised trial (GABG-IV E-93) - the German Adjuvant Breast Cancer Group.
Eur J Cancer
; 46(1): 84-94, 2010 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-19879750
Resultados
1 -
14
de 14
1
Próxima >
>>